2026 Q2 - tulosraportti
Vain PDF
42 päivää sitten
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 20.8. | ||
2026 Q1 - tulosraportti 7.5. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 22.10.2025 | ||
2025 Q2 - tulosraportti 21.8.2025 |
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·23 t sittenIt looks like the protests from citizens and lawyers have worked, because this morning, Hanf Journal has an article stating that German politicians are not as steadfast as they have been ever since the approval of the legislation on July 30, 2026. Below is not approved yet, but has been sent for political negotiation. People still have to pay for the flower medicine themselves, out of their own pocket. What is being changed is. the quarantine is being removed for new patients. But if a person has a diagnosis, such as MS, the doctor must write a prescription for cannabis oil approved for this disease first before the doctor may write a prescription for other factory-pre-mixed cannabis oils. All other diseases, which these 4 oils are not approved for, the doctor can write a prescription for other oils ex. Weeco Astrum10/10 as the first choice. https://hanfjournal.de/2026/09/30/cannabis-auf-kassenrezept-koalition-will-starre-erstverordnung-zuruecknehmen/- ·1 päivä sittenstock status Now Medcanonestop is up to 6 pharmacies that have got Weeco Astrum10/10 in stock. The pharmacy in Essen has got Weeco Astrum10/10 back in stock. There are only two platforms that haven't got the oil in stock yet. Cannanow and Pink blom. (it looks like there are more pharmacies that haven't got the oil approved for sale yet, I can only see that when the oil is approved for sale)I cannot edit the above so therefore this addendum. This article is from the pharmacies to the citizens. Pharmacies have contacted the ministry directly to clarify whom pharmacies are allowed to dispense cannabis oil to, without charge from the customer. They asked the ministry directly because pharmacies are also subject to the hated "regress system" just like doctors, and therefore pharmacies want to ensure that no more pharmacies are exposed to the hated system. For those of you who have not heard about this previously. This means that pharmacies must pay out of pocket if they dispense medicine for free to a customer who was supposed to pay for the medicine themselves. At the bottom of the article from the pharmacies to the citizens in Germany. "A mandatory switch to finished medicinal products for patients who are already receiving extracts is therefore no longer necessary," writes Dr. Christiane Neubaur's spokesperson. The six-month trial period thus only applies to new prescriptions. According to the KBV's interpretation, even those who have previously received cannabis flowers can waive the trial period and receive an extract directly. https://www.apotheken-umschau.de/medikamente/keine-cannabisblueten-mehr-auf-kassenrezept-was-das-fuer-diese-patienten-bedeutet-1567763.html
- ·2 päivää sitteninventory status Today, a pharmacy in Bavaria has received Weeco Astrum 10/10 in stock. Not all platforms have received the oil in stock yet, but I think it is only a matter of a short time before all those that had the oil in stock before it sold out will get it again. The only thing the pharmacies are waiting for is for their test of the oil to be approved. I am starting to believe that the batch that Stenocare has sent to Germany, Weeco Pharma has received approval to forward the oil to the pharmacies that have placed an order.
·2 päivää sittenLooking at the share price, there is nothing positive to see in my opinion. A fall of 95.96 % is indeed deeply concerning. Because we are indeed under 1 kr. now and trading is very small. Even though there is a larger turnover in 2026, it seems that the road ahead is very long. This company still has a great deal of work ahead of it. I have been in this stock for a long time, but for me personally there has been more downside to it than ups. The price can go down even further and it can rise again. That has been seen before. What do you others think? Have you maintained your optimism and what does it take for the stock to become a winner?I first got into this stock in Q4 because I believed there is a probability that Stenocare is going to make money. I base this on the fact that doctors have become more comfortable prescribing standard medical cannabis, because gradually several different evidences have emerged that standardized cannabis oils can replace other medicine with many unfortunate side effects including opioids, and most importantly, that no concerning side effects have been registered with medical cannabis oil. So I believe in the product, but the management bob... bob... bob- ·25.9.inventory status Another pharmacy in Stuttgart has got Weeco Pharma in stock. My optimism is rising,
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 - tulosraportti
Vain PDF
42 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·23 t sittenIt looks like the protests from citizens and lawyers have worked, because this morning, Hanf Journal has an article stating that German politicians are not as steadfast as they have been ever since the approval of the legislation on July 30, 2026. Below is not approved yet, but has been sent for political negotiation. People still have to pay for the flower medicine themselves, out of their own pocket. What is being changed is. the quarantine is being removed for new patients. But if a person has a diagnosis, such as MS, the doctor must write a prescription for cannabis oil approved for this disease first before the doctor may write a prescription for other factory-pre-mixed cannabis oils. All other diseases, which these 4 oils are not approved for, the doctor can write a prescription for other oils ex. Weeco Astrum10/10 as the first choice. https://hanfjournal.de/2026/09/30/cannabis-auf-kassenrezept-koalition-will-starre-erstverordnung-zuruecknehmen/
- ·1 päivä sittenstock status Now Medcanonestop is up to 6 pharmacies that have got Weeco Astrum10/10 in stock. The pharmacy in Essen has got Weeco Astrum10/10 back in stock. There are only two platforms that haven't got the oil in stock yet. Cannanow and Pink blom. (it looks like there are more pharmacies that haven't got the oil approved for sale yet, I can only see that when the oil is approved for sale)I cannot edit the above so therefore this addendum. This article is from the pharmacies to the citizens. Pharmacies have contacted the ministry directly to clarify whom pharmacies are allowed to dispense cannabis oil to, without charge from the customer. They asked the ministry directly because pharmacies are also subject to the hated "regress system" just like doctors, and therefore pharmacies want to ensure that no more pharmacies are exposed to the hated system. For those of you who have not heard about this previously. This means that pharmacies must pay out of pocket if they dispense medicine for free to a customer who was supposed to pay for the medicine themselves. At the bottom of the article from the pharmacies to the citizens in Germany. "A mandatory switch to finished medicinal products for patients who are already receiving extracts is therefore no longer necessary," writes Dr. Christiane Neubaur's spokesperson. The six-month trial period thus only applies to new prescriptions. According to the KBV's interpretation, even those who have previously received cannabis flowers can waive the trial period and receive an extract directly. https://www.apotheken-umschau.de/medikamente/keine-cannabisblueten-mehr-auf-kassenrezept-was-das-fuer-diese-patienten-bedeutet-1567763.html
- ·2 päivää sitteninventory status Today, a pharmacy in Bavaria has received Weeco Astrum 10/10 in stock. Not all platforms have received the oil in stock yet, but I think it is only a matter of a short time before all those that had the oil in stock before it sold out will get it again. The only thing the pharmacies are waiting for is for their test of the oil to be approved. I am starting to believe that the batch that Stenocare has sent to Germany, Weeco Pharma has received approval to forward the oil to the pharmacies that have placed an order.
- ·2 päivää sittenLooking at the share price, there is nothing positive to see in my opinion. A fall of 95.96 % is indeed deeply concerning. Because we are indeed under 1 kr. now and trading is very small. Even though there is a larger turnover in 2026, it seems that the road ahead is very long. This company still has a great deal of work ahead of it. I have been in this stock for a long time, but for me personally there has been more downside to it than ups. The price can go down even further and it can rise again. That has been seen before. What do you others think? Have you maintained your optimism and what does it take for the stock to become a winner?I first got into this stock in Q4 because I believed there is a probability that Stenocare is going to make money. I base this on the fact that doctors have become more comfortable prescribing standard medical cannabis, because gradually several different evidences have emerged that standardized cannabis oils can replace other medicine with many unfortunate side effects including opioids, and most importantly, that no concerning side effects have been registered with medical cannabis oil. So I believe in the product, but the management bob... bob... bob
- ·25.9.inventory status Another pharmacy in Stuttgart has got Weeco Pharma in stock. My optimism is rising,
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 20.8. | ||
2026 Q1 - tulosraportti 7.5. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 22.10.2025 | ||
2025 Q2 - tulosraportti 21.8.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Välittäjätilasto
Dataa ei löytynyt
2026 Q2 - tulosraportti
Vain PDF
42 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 - tulosraportti 29.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 - tulosraportti 20.8. | ||
2026 Q1 - tulosraportti 7.5. | ||
2025 Q4 - tulosraportti 26.2. | ||
2025 Q3 - tulosraportti 22.10.2025 | ||
2025 Q2 - tulosraportti 21.8.2025 |
Tuotteita joiden kohde-etuutena tämä arvopaperi
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·23 t sittenIt looks like the protests from citizens and lawyers have worked, because this morning, Hanf Journal has an article stating that German politicians are not as steadfast as they have been ever since the approval of the legislation on July 30, 2026. Below is not approved yet, but has been sent for political negotiation. People still have to pay for the flower medicine themselves, out of their own pocket. What is being changed is. the quarantine is being removed for new patients. But if a person has a diagnosis, such as MS, the doctor must write a prescription for cannabis oil approved for this disease first before the doctor may write a prescription for other factory-pre-mixed cannabis oils. All other diseases, which these 4 oils are not approved for, the doctor can write a prescription for other oils ex. Weeco Astrum10/10 as the first choice. https://hanfjournal.de/2026/09/30/cannabis-auf-kassenrezept-koalition-will-starre-erstverordnung-zuruecknehmen/
- ·1 päivä sittenstock status Now Medcanonestop is up to 6 pharmacies that have got Weeco Astrum10/10 in stock. The pharmacy in Essen has got Weeco Astrum10/10 back in stock. There are only two platforms that haven't got the oil in stock yet. Cannanow and Pink blom. (it looks like there are more pharmacies that haven't got the oil approved for sale yet, I can only see that when the oil is approved for sale)I cannot edit the above so therefore this addendum. This article is from the pharmacies to the citizens. Pharmacies have contacted the ministry directly to clarify whom pharmacies are allowed to dispense cannabis oil to, without charge from the customer. They asked the ministry directly because pharmacies are also subject to the hated "regress system" just like doctors, and therefore pharmacies want to ensure that no more pharmacies are exposed to the hated system. For those of you who have not heard about this previously. This means that pharmacies must pay out of pocket if they dispense medicine for free to a customer who was supposed to pay for the medicine themselves. At the bottom of the article from the pharmacies to the citizens in Germany. "A mandatory switch to finished medicinal products for patients who are already receiving extracts is therefore no longer necessary," writes Dr. Christiane Neubaur's spokesperson. The six-month trial period thus only applies to new prescriptions. According to the KBV's interpretation, even those who have previously received cannabis flowers can waive the trial period and receive an extract directly. https://www.apotheken-umschau.de/medikamente/keine-cannabisblueten-mehr-auf-kassenrezept-was-das-fuer-diese-patienten-bedeutet-1567763.html
- ·2 päivää sitteninventory status Today, a pharmacy in Bavaria has received Weeco Astrum 10/10 in stock. Not all platforms have received the oil in stock yet, but I think it is only a matter of a short time before all those that had the oil in stock before it sold out will get it again. The only thing the pharmacies are waiting for is for their test of the oil to be approved. I am starting to believe that the batch that Stenocare has sent to Germany, Weeco Pharma has received approval to forward the oil to the pharmacies that have placed an order.
- ·2 päivää sittenLooking at the share price, there is nothing positive to see in my opinion. A fall of 95.96 % is indeed deeply concerning. Because we are indeed under 1 kr. now and trading is very small. Even though there is a larger turnover in 2026, it seems that the road ahead is very long. This company still has a great deal of work ahead of it. I have been in this stock for a long time, but for me personally there has been more downside to it than ups. The price can go down even further and it can rise again. That has been seen before. What do you others think? Have you maintained your optimism and what does it take for the stock to become a winner?I first got into this stock in Q4 because I believed there is a probability that Stenocare is going to make money. I base this on the fact that doctors have become more comfortable prescribing standard medical cannabis, because gradually several different evidences have emerged that standardized cannabis oils can replace other medicine with many unfortunate side effects including opioids, and most importantly, that no concerning side effects have been registered with medical cannabis oil. So I believe in the product, but the management bob... bob... bob
- ·25.9.inventory status Another pharmacy in Stuttgart has got Weeco Pharma in stock. My optimism is rising,
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Rahastot ja ETF:t, joilla on osaketta
Mikään rahasto ei ilmoita osaketta kymmenen suurimman omistuksensa joukossa.
Asiakkaat katsoivat myös
Välittäjätilasto
Dataa ei löytynyt